>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Calcium Channel>>Lercanidipine hydrochloride

Lercanidipine hydrochloride

Catalog No.GC10590

레르카니디핀 염산염은 친유성 3세대 디히드로피리딘-칼슘 채널 차단제(DHP-CCB)입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Lercanidipine hydrochloride Chemical Structure

Cas No.: 132866-11-6

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$43.00
재고 있음
10mg
US$40.00
재고 있음
50mg
US$141.00
재고 있음
100mg
US$209.00
재고 있음
200mg
US$281.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lercanidipine hydrochloride is a calcium channel blocker of the dihydropyridine class.Target: Calcium ChannelLercanidipine is a calcium channel blocker of the dihydropyridine class, which works by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body. Lercanidipine was effective and well-tolerated in patients with mild-to-moderate hypertension in the daily practice. The effectiveness and safety of the drug were independent of the degree of cardiovascular risk [1, 2].

References:
[1]. Barrios, V., et al., Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. Int J Clin Pract, 2006. 60(11): p. 1364-70.
[2]. Burnier, M., M. Pruijm, and G. Wuerzner, Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine Expert Opin Drug Metab Toxicol, 2009. 5(8): p. 981-7.

리뷰

Review for Lercanidipine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lercanidipine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.